17th June 2026

Pharmanovia appoints Julia Schüssler as Chief People and Culture Officer and John Parsons as General Counsel to support next phase of growth

FOR IMMEDIATE RELEASE – BASILDON, UK, 17 JUNE 2026  Pharmanovia, a global specialty pharmaceutical company, has...

More information
15th December 2025

Pharmanovia announces a first-in-class drug therapy treatment

PRESS RELEASE – FOR TRADE AND BUSINESS MEDIA ONLY PHARMANOVIA ANNOUNCES LAUNCH OF KORJUNY (CATUMAXOMAB) IN...

More information
1st October 2025

Pharmanovia appoints Stephan Eder as Chief Executive Officer

For immediate release, 1st October 2025, Basildon, UK: Pharmanovia today announced the appointment of Stephan Eder as...

More information
10th April 2025

Pharmanovia Leadership Update

FOR IMMEDIATE RELEASE – BASILDON, UK, 10th APRIL 2025  Pharmanovia, a global pharmaceutical company that commercialises...

More information
1st April 2025

Pharmanovia acquires exclusive rights to novel antipsychotic treatment

BASILDON, UK, 1st April 2025 Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises,...

More information
21st February 2025

Pharmanovia announces exclusive distribution agreement with Er-Kim for Sunosi® in Eastern Europe

PRESS RELEASE – FOR TRADE AND BUSINESS MEDIA ONLY Basildon, UK – 21 February 2025 Pharmanovia,...

More information
14th February 2025

Lindis Biotech and Pharmanovia announce European marketing authorisation approval for a first-in-class treatment

PRESS RELEASE – FOR TRADE AND BUSINESS MEDIA ONLY MUNICH, GERMANY, AND BASILDON, UK, 13 February...

More information
2nd January 2025

Pharmanovia signs in-licensing deal for novel osteoporosis treatment with Radius Health

BASILDON, UK, 02 January 2025 Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises,...

More information
23rd December 2024

Pharmanovia announces submission of Paediatric Investigational Plan (PIP) for elamipretide to the medicines and healthcare product regulatory agency (MHRA)

PRESS RELEASE – FOR TRADE, MEDICAL AND BUSINESS MEDIA ONLY BASILDON, UK, 20 December 2024 Pharmanovia,...

More information

For all media enquiries please contact: communications@pharmanovia.com